EX-10.41



 






EXHIBIT 10.41




POLICY OF ENDO PHARMACEUTICALS HOLDINGS INC.

RELATING TO INSIDER TRADING IN COMPANY

SECURITIES AND CONFIDENTIALITY OF INFORMATION




	 	 	 
	To:

	 	All Personnel
	From:

	 	Carol A. Ammon, Chairman & Chief Executive Officer






      The Board of Directors has adopted the following Policy which applies to all personnel
(including directors and officers) of Endo Pharmaceuticals Holdings Inc. and its subsidiaries
(collectively called the “Company”) arising from our legal and ethical responsibilities as a public
company.



      1. Prohibition Against Trading on Undisclosed Material Information: If you are aware of
material information relating to the Company which has not yet been available to the public for at
least two full days (often called “inside information”), you are prohibited from trading in our
securities, directly or indirectly, and from disclosing such information to any other persons who
may trade in our securities. Any information, positive or negative, is “material” if it might be
of significance to an investor in determining whether to purchase, sell or hold our securities.
Information may be significant for this purpose even if it would not alone determine the investor’s
decision. Examples include a potential business acquisition, internal information about revenues,
earnings or other aspects of financial performance which departs in any way from what the market
would expect based upon prior disclosures, important business developments (including FDA approval
or nonapproval of one of our products), the acquisition or loss of major customer, or an important
transaction. We emphasize that these examples are merely illustrative. When we refer to our
“securities” we mean both the Company’s common stock and the Company’s warrants.



      Once material information is publicly announced, trading can occur after a lapse of two
full trading days. Therefore, if an announcement is made before the commencement of trading on a
Monday, an employee may trade in the Company’s stock or warrants starting on the Wednesday of that
week, because two full trading days would have elapsed by then (all of Monday and Tuesday). If the
announcement is made on Monday after trading begins, employees may not trade in the Company’s stock
or warrants until Thursday. Please consult myself, Jeffrey R. Black or Caroline B. Manogue if you
are uncertain when trading may commence following an announcement.



 








 





      The above prohibition against trading on inside information generally reflects the
requirements of law as well as the Company’s Policy. As more fully discussed fully discussed
below, a breach of this Policy probably will constitute a serious legal violations as well.



      2. Restricted Periods: In addition to the limitations set forth in Section 1 above, no
personnel should trade any securities of the Company during periods that begin 10 trading days
prior to the end of each of the Company’s fiscal quarters (including its fiscal year end) and
ending two full trading days after the financial results for each quarter, or with respect to the
fourth quarter for the full year, have been announced publicly (the “Restricted Period”). The
Company’s fiscal quarters end on each March 31, June 30 and September 30 and its fiscal year end is
December 31. The announcement date of the quarterly results varies, but occurs normally around the
45th day following the end of the fiscal quarter. For example, you cannot trade any
securities of the Company from June 15th until August 18th, two full trading
days after the second quarter results are publicly announced. Notwithstanding the foregoing,
personnel may sell any securities of the Company during a Restricted Period if such securities are
sold pursuant to an effective registration statement on Form S-3 or Form S-4 or any successor form
thereto on file with the U.S. Securities and Exchange Commission (an “Exempted Sale”) and such
personnel have received the consent of Jeffrey R. Black or Caroline B. Manogue prior to conducting
such sale. Furthermore, upon the receipt of a notice by mail, fax or email from the Company
informing personnel of an Exempted Sale, all personnel may trade any securities of the Company, if
such personnel shall have first received the consent of Jeffrey R. Black or Caroline B. Manogue to
conduct such sale, until such time as the Exempted Sale is consummated, but in no case for more
than three business days from the date of such notice.



      3. Confidentiality Generally: Serious problems arise from the unauthorized disclosure of
internal information about the Company (or confidential information about our customers or
vendors), whether or not the purpose of facilitating improper trading in our stock. Accordingly,
the Company’s confidentiality policy remains the same but is supplemented by this Policy. Company
personnel should not discuss internal Company matters or developments with anyone outside of the
Company, except as required in the performance of regular corporate duties.



      This prohibition applies specifically (but not exclusively) to inquiries about the Company
which may be made by the financial press, investment analyst or others in the financial community.
It is important that all such communications on behalf of the Company be made only through an
appropriately designated officer under carefully controlled circumstances. Unless you are
expressly authorized to the



 








 






contrary, if you receive any inquiries of this nature, you should decline comment and refer
the inquiry to Jeffrey R. Black or Caroline B. Manogue (or their respective successors as Chief
Financial Officer and Corporate Secretary).



      4. Information About Other Companies: In the course of your employment, you may become aware
of material non-public information about other public companies – for example, other companies with
which our Company has business dealings. You are prohibited from trading in the securities of any
other public company at a time when you are in possession of material non-public information about
such company.



      5. Tipping: Improper disclosure of non-public information to another person who trades in the
stock (so-called “tipping”) is also a serious legal offense by the tipper and a violation of the
terms of this Policy. If you disclose information about our Company, or information about any
other public company which you acquire in connection with your employment with our Company, you may
be fully responsible legally for the trading of the person receiving the information from you (your
“tippee”) and even persons who receive the information directly or indirectly from your tippee.
Accordingly, in addition to your general obligations to maintain confidentiality of information
obtained through your employment and to refrain from trading while in possession of such
information, you must take utmost care not to discuss confidential or non-public information with
family members, friends or others who might abuse the information by trading in securities.



      6. Limitation on Certain Trading Activities: We encourage interested employees to own
securities as a long-term investment at levels consistent with their individual financial
circumstances and risk bearing abilities (since ownership of any security entails risk). However,
Company personnel may not trade in puts, calls or similar options on our stock or sell our stock
“short”. (You may, of course, exercise any stock options granted to you by the Company in
accordance with their terms.)



      7. Consequence of Violation: The Company considers strict compliance with this Policy to be a
matter of utmost importance. We would consider any violation of this Policy by an employee as a
threat to our reputation. Violation of this Policy could cause extreme embarrassment and possible
legal liability to you and the Company. Knowing or willful violations of the letter or spirit of
this Policy will be grounds for immediate dismissal from the Company. Violation of the Policy
might expose the violator to severe criminal penalties as well as civil liability to any person
injured by the violation. The monetary damages flowing from a violation could be three times the
profit realized by the violator, as well as the attorneys’ fees of the persons injured.



 








 





      8. Resolving Doubts: If you have any doubt as to your responsibilities under this Policy,
seek clarification and guidance before you act from Jeffrey R. Black or Caroline B. Manogue (or
their respective successors as Chief Financial Officer and Chief Legal Officer). Do not try to
resolve uncertainties on your own.



      9. A Caution About Possible Inability to Sell: Although the Company encourages employees to
own our securities as a long-term investment (See Section 6), all personnel must recognize that
trading in securities may be prohibited at a particular time because of the existence of material
non-public information. Anyone purchasing our securities must consider the inherent risk that a
sale of the securities could be prohibited at a time he or she might desire to sell them. The next
opportunity to sell might not occur until after an extended period, during which the market price
of the securities might decline.



      10. 10b5-1 Trading Plans. Notwithstanding the foregoing, the Company’s Directors and
Executive Officers are permitted to establish trading plans in compliance with Rule 10b5-1(c) of
the Securities Exchange Act of 1934, as amended (each, a “Trading Plan”); provided
that any such plan must first be approved by Jeff Black and Caroline Manogue (or their
respective successors as Chief Financial Officer and General Counsel) prior to its implementation;
and provided further that any such plan shall provide that the Company may
terminate said plan for any reason.



*******